🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

a SIngle Center Study of Post-operative STEReotactic RAdiotherapY for Endometrial Cancer

RecruitingNAAges 18 Years - 80 YearsFemaleARNAS Civico Di Cristina Benfratelli Hospital
NCT06360653 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The primary endpoint of the present prospective study is to assess the outcomes in terms of acute toxicity of post-operative stereotactic radiotherapy for endometrial cancer

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
* Age 18-80 years * ECOG PS ≤ 2 or KPS ≥ 70% * Patients diagnosed with endometrial cancer (endometrioid, serous cell, clear cell, carcinosarcoma) FIGO stage IB-IIIC1 candidate to post-operative external beam radiotherapy, based on molecular and histological findings * Indications for chemotherapy and/or brachytherapy are not exclusion criteria for the purpose of the study * Written Informed Consent Exclusion Criteria: * Prior pelvic radiotherapy * Para-aortic lymph nodes involvement * ECOG PS ≥ 3 * Any diagnosis of inflammatory bowel disease (both active or quiescent)
💊

What it tests

  • Stereotactic Post-operative Radiotherapy for Endometrial Cancer
📍

Where

2 sites
ARNAS Civico Hospital
Palermo, Italy
ARNAS Civico Hospital
Palermo, Italy
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy